Loading...
Loading...
On Wednesday, J.P. Morgan set a price target of $700, the highest on the Street, on shares of
Intuitive SurgicalISRG and upgraded the stock from Market Underperform to Market Outperform.
Analyst J.T. Haresco believes a large share of the company's prior models in the United States will be replaced in favor of da Vinci Xi as the auto-deployment feature will cut setup time.
Revenue growth could increase to 16 percent from 0.3 percent from demand for the new system, the analyst said.
Details on the new da Vinci Xi surgical system can be found here.
Shares of Intuitive are up another 3.5 percent to $510.88 after gaining 12 percent on Tuesday. Haresco's $700 price target implies 37 percent upside from current levels.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in